By Healthcare Edge Editorial Staff Eterna Therapeutics Inc. (Nasdaq: ERNA) said it appointed Sanjeev Luther as incoming President and Chief Executive Officer from Jan. 1, 2024. Mr. Luther emphasized his commitment to advancing the reach and promise of mRNA cell...

By Healthcare Edge Editorial Staff ProSomnus, Inc. (NASDAQ: OSA), a pioneer in non-CPAP Obstructive Sleep Apnea (OSA) therapy, has revealed that its precision oral appliance therapy (OAT) devices effectively treat OSA, according to a study published by the Cureus Journal...

By Tech Edge Editorial Staff Real estate technology company reAlpha Tech Corp. (Nasdaq: AIRE) said it is set to acquire United Software Group, a global IT consulting company based in Ohio, to boost its AI capabilities. The acquisition should help...

PE Edge hosted a fireside chat from the floor of the New York Stock Exchange with Jason Chudoba, Partner at ICR. Mr. Chudoba spoke to PE Edge Editor-at-Large Jarrett Banks about the impact of interest rates on the real estate...

IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange with George Kirby, CEO at RS Technologies. Mr. Kirby spoke to IPO Edge Editor-in-Chief John Jannarone about how the electric utility industry is currently expanding,...

  By Tech Edge Editorial Staff Tech Edge and Exec Edge are please to provide video coverage of the third annual Palm Beach CorpGov Forum, which was held on Nov. 8, featuring a full day of panels and fireside chats....

By Thomas S. Green Apollomics Inc. (Nasdaq: APLM) said it saw strong results from two clinical trials for Vebreltinib, designed to target non-small cell lung cancer and other advanced tumors. The trials showed that patients without co-occurring MET amplification had...

By Thomas S. Green The Duckhorn Portfolio, Inc. (NYSE: NAPA) said fiscal first quarter net income was $15.5 million, compared to $19.8 million in the prior year period. “We delivered a quarter at the high end of our expectations as...

By Thomas S. Green Vince Holding Corp. (NYSE: VNCE) said third quarter gross profit was $37.2 million, or 44.2% of net sales, compared to gross profit of $29.8 million, or 30.2% of net sales, in the third quarter of fiscal...

By Healthcare Edge Editorial Staff Octave Bioscience, Inc. said Founder William Hagstrom will become Chairman of the Board, while Doug Biehn is the new President and CEO. Mr. Biehn has over 20 years of experience in healthcare, building and scaling...